Hemotune AG
Series BZurich, SwitzerlandApr 2022
Hemotune AG raised €7.1M in a Series B round in Apr 2022. The company is based in Zurich, Switzerland. Investors in the round: Hemex, OCCIDENT, VP Venture Partners and 1 other. Data as of Nov 2026.
Amount raised
€7.1M
€7,087,692
Native amount
7,250,000 CHF
Stage
Series B
series b
Investors
4
Provenance & confidence
High confidenceAmount
7,250,000 CHF
ECB-at-date → €7.1M · rate 1.0229 on 2022-04-26
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Apr 2022
Round type
series b
Amount (EUR)
€7.1M
Other rounds
same companyThis is the company's only recorded round.
Related news
- CHF 7.25 million for a platform reducing the burden of sepsisstartupticker.ch · 2022-04